Condition (MeSH)
Dextrocardia
ClinicalTrials.gov lists 22 trials for Dextrocardia or a narrower condition beneath it. ReCode Therapeutics has the most among industry and government lead sponsors, with 4.
Search trials, drugs, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Trials per phase
1 of the 22 trials are tagged with Dextrocardia itself; the rest are tagged with a narrower condition beneath it.
When did Dextrocardia trials start? (15)
Shown in this order: most recent first, 1990 onwards. 2026 is partial: trials registered with a 2026 start date so far, not a full year.
Trials over time, by phase
- Phase 1
- Not applicable
- Observational
Top of scale: 3
Trials registered with a start date in each year, 1990 onward, stacked by phase (complete years only; the current partial year is in the table's notes). The table below lists the same counts, most recent years first.
| Year | Trials started |
|---|---|
| 2025 | 1 |
| 2024 | 2 |
| 2023 | 2 |
| 2022 | 1 |
| 2021 | 1 |
| 2020 | 3 |
| 2019 | 1 |
| 2015 | 1 |
| 2014 | 1 |
| 2013 | 2 |
Showing 10 of 15 earlier years.
No forecast is made for this condition: it averages 1.2 trial starts a year over the five years to September, under the 5 a year the method needs.
Recruitment duration, a model prediction: none of the 22 trials evaluated at the 2026-10-09 snapshot is predicted and still running. Source: ClinicalTrials.gov / AACT (CTTI), public domain.
What phase are Dextrocardia trials in? (3)
Shown in this order: phase order.
Show the trials by phase as a table
| Phase | Trials |
|---|---|
| Phase 1 | 3 |
| Not applicable | 1 |
| Observational | 18 |
How many Dextrocardia trials are recruiting? (3)
Shown in this order: the order a trial moves through, from not yet recruiting to unknown.
| Status | Trials |
|---|---|
| Recruiting | 5 |
| Active, not recruiting | 1 |
| Completed | 16 |
Status as registered on ClinicalTrials.gov. Each trial is counted once.
Which lead sponsors run the most Dextrocardia trials? (2)
Shown in this order: most trials first. Lead sponsors the registry classes as industry, NIH, US federal, other government or network. A hospital or university the registry files as government can appear here. Sponsors it classes as academic or other are shown on the full page, because that class cannot separate an institution from a named investigator.
| Sponsor | Trials |
|---|---|
| ReCode Therapeutics | 4 |
| National Institute of Allergy and Infectious Diseases (NIAID) | 1 |
Interventions as named in the registry (4)
Shown in this order: most trials first.
| Drug | Trials |
|---|---|
| RCT1100 | 3 |
| data collection | 1 |
| Home-based therapy | 1 |
| BLOOD SAMPLE | 1 |
These are the names sponsors entered on ClinicalTrials.gov that we have not matched to a single molecule. Some are drugs under a brand or code name; others are procedures, doses or arm labels.
Which publications cover Dextrocardia? (2)
Shown in this order: major-topic papers first, then newest, then most linked to trials.
| Publication | Journal | Year | Major topic |
|---|---|---|---|
| ANATOMIC TYPES OF CONGENITAL DEXTROCARDIA: DIAGNOSTIC AND EMBRYOLOGIC IMPLICATIONS. | The American journal of cardiology | 1964 | Yes |
| Kartagener's syndrome seen on CT. | Computerized radiology : official journal of the Computerized Tomography Society | 1985 | No |
Prevalence (3)
Shown in this order: jurisdiction, then disease name. Orphanet observation for the mapped ORPHA concept; the mapping relation column says whether that concept is exactly this condition or broader or narrower.
| Orphanet disease | Type | Class | Geography | Jurisdiction | Mapping relation |
|---|---|---|---|---|---|
| Dextrocardia | Point prevalence | Unknown | Worldwide | Not stated | Exact |
| Dextrocardia | Point prevalence | Unknown | Worldwide | Not stated | Unspecified |
| Dextrocardia | Point prevalence | Unknown | Worldwide | Not stated | Exact |
Rare-disease identity (2)
Shown in this order: exact, broader, narrower, other.
| Orphanet disease | ORPHA code | Relation | Source |
|---|---|---|---|
| Dextrocardia | 1666 | Exact | Orphanet Rare Disease Ontology (ORDO) |
| Dextrocardia | 1666 | Exact | Orphadata Science knowledge files, Product 1 |
Sub-conditions in MeSH (1)
MeSH descendants one level down with at least one trial, most trials first.
Not on this page
Not measured: delivery record.
Checked, with nothing recorded for this condition: serious adverse events in this condition's trials.